High-dose estradiol therapy for reduction of final height may be compl
icated by severe side effects such as deep vein thrombosis. We report
a 14.6-year-old girl with tall stature. In order to reduce final heigh
t she was treated with ethinylestradiol and medroxyprogesterone. After
arthroscopy she suffered acute deep venous thrombosis of her left leg
. Despite being monitored at short intervals, coagulation parameters s
uch as AT III and protein C indicated no development of thrombosis. Me
dical height reduction with estrogen should be accompanied by heparini
sation during longer-lasting periods of immobilisation.